Digital biomarkers are emerging as important predictive tools to support the global Covid-19 pandemic
Focus:
-
![US Covid-19 cases]()
Nearly 70 potential Covid-19 drug and experimental compound candidates identified
-
![regulators advanced therapies]()
Tips and tricks for regulating advanced therapies
-
![melanoma]()
Triplet combinations emerging in the first-line treatment of melanoma
-
![]()
More data needed to support the use of hydroxychloroquine for Covid-19
-
![itca 650]()
Intarcia’s diabetes drug implant ITCA 650 receives second FDA rejection
-
![Covid-19 pandemic]()
Covid-19 vaccine availability unlikely to hit 12–18 month timelines being touted
Most Read
Company A-Z
Latest Content
Gilead initiates two studies of remdesivir for Covid-19 in UK
Gilead Sciences has launched two Phase III clinical trials of its investigational antiviral drug remdesivir in the UK to treat Covid-19 patients.
Butterworth Laboratories Continues To Support the Pharmaceutical Industry During Covid-19 Crisis
Keeping the supply chain of life-saving and life-changing drugs functioning efficiently is demanding under normal circumstances, so the difficulties experienced during these unprecedented times are intensifying an already challenging predicament.
EMA advises malaria drugs use for trials only; FDA records shortage
The European Medicines Agency (EMA) has urged that two malaria drugs, chloroquine and hydroxychloroquine, being tested as potential Covid-19 treatment must only be used for clinical trials or national emergency use programmes.
Software Solution for Digitalisation of Recipe Management
Challenges and risks associated with the recipe management process in the life sciences industry can be overcome by the introduction of MePIS RM software solution.
Cleaning Validation for Pharmaceutical Manufacturing
Cleaning validation is a requirement for pharmaceutical manufacturing, which adheres to current good manufacturing practice (cGMP) and quality systems regulations (QSR).
SHL Medical Acquires Weibel CDS
SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging.
Tips and tricks for regulating advanced therapies
While transforming and re-focusing pharma towards long-term treatments, advanced therapies have also pose significant challenges to regulators who are trying to figure out how to approve and reimburse these innovative medicines. Allie Nawrat spoke to the Alliance for Regenerative Medicine about its recommendations for regulators in this complicated, ever-evolving space.
Latest News
Read our magazine
Pharma Technology Focus is the essential reading material for decision-makers in the pharmaceutical industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top